Performance with such samples cannot be guaranteed, as differences in expression, sequence, tags, folding, post-translational modifications, purity, activity, or buffer composition may affect assay results
We Know Enough to Pivot Towards This Opportunity When mRNA vaccines were proposed and funded for COVID, they were an untested technology being developed for a novel virus
Presented for research literature review only Vuksic T et al
Shawn Dillon The rating of this product is 5 out of 5 Super friendly and very helpful
William Bao Bean, General Partner & Managing Director of Sosv/Chinaccelerator/Mox
10.1038/ng.654 127 WatanabeK.KuriharaK.SuzukiT